AVAH vs MRNA · P/E 149, rev $1.32B vs rev $145.0M
Aveanna Healthcare Holdings Inc (AVAH) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Aveanna Healthcare Holdings Inc (AVAH) is a medical care facilities company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported AVAH revenue for 2026-07-04 was $1.32B. Net income was $81.9M. AVAH currently screens at market cap $920.0M and trailing P/E 148.7.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
AVAH currently screens at market cap $920.0M and trailing P/E 148.7. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the AVAH and MRNA stock pages for the full models.
Not investment advice.